Security key
98420X103
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR)
CUSIP: 98420X103
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 94,372,096
- Total 13F shares
- 7,594,683
- Share change
- +5,815,786
- Total reported value
- $113,920,545
- Price per share
- $15.00
- Number of holders
- 43
- Value change
- +$87,071,950
- Number of buys
- 37
- Number of sells
- 4
Report period
Q2 2019
Institutions
43
Top holders
10
XFOR full security history
Newer quarter: Q3 2019
Previous quarter: Q1 2019
X4 Pharmaceuticals, Inc SEC filings
X4 Pharmaceuticals, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420X103
Recent filing periods:
Top shareholders of XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
0.35%
|
333,333
|
$5,803,000 | — | 31 Mar 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.33%
|
311,493
|
$5,423,000 | — | 31 Mar 2019 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
0.33%
|
311,492
|
$5,423,000 | — | 31 Mar 2019 | |
| SV Health Investors, LLC |
13F
|
Company |
0.33%
|
311,490
|
$5,423,000 | — | 31 Mar 2019 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.27%
|
252,749
|
$4,400,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.09%
|
86,272
|
$1,502,000 | — | 31 Mar 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.07%
|
68,567
|
$1,194,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
39,877
|
$694,000 | — | 31 Mar 2019 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
0.02%
|
20,730
|
$361,000 | — | 31 Mar 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
17,692
|
$308,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
12,902
|
$224,000 | — | 31 Mar 2019 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
10,001
|
$174,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,053
|
$69,000 | — | 31 Mar 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,131
|
$37,000 | — | 31 Mar 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,179
|
$21,000 | — | 31 Mar 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
833
|
$14,000 | — | 31 Mar 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
551
|
$10,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
494
|
$8,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
450
|
$8,000 | — | 31 Mar 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
443
|
$8,000 | — | 31 Mar 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
361
|
$7,000 | — | 31 Mar 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
392
|
$6,000 | — | 31 Mar 2019 | |
| Cable Hill Partners, LLC |
13F
|
Company |
0%
|
266
|
$5,000 | — | 31 Mar 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
245
|
$4,000 | — | 31 Mar 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
221
|
$4,000 | — | 31 Mar 2019 | |
| STRS OHIO |
13F
|
Company |
0%
|
216
|
$3,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
166
|
$3,000 | — | 31 Mar 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
132
|
$2,000 | — | 31 Mar 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
64
|
$1,000 | — | 31 Mar 2019 |
Institutional Holders of X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR) as of Q2 2019
As of 30 Jun 2019,
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,594,683 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Cormorant Asset Management, LP, RA CAPITAL MANAGEMENT, LLC, BVF INC/IL, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BlackRock Inc., NEA Management Company, LLC, and Polaris Venture Management Co. V, L.L.C..
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
29
Q2 2019 holders
43
Holder diff
14
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.